β1 integrin is required for anchorage-independent growth and invasion of tumor cells in a context dependent manner

Cancer Letters

Volumn 316, Issue 2, 2012, Pages 157-167

  Schooley, Allana M ^a,b   Andrews, Natalie M ^a,b   Zhao, Huijun ^a   Addison, Christina L ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

1 integrin; Anchorage independent growth; Fibronectin; Invasion; RNA interference; Tumor

Indexed keywords

BETA1 INTEGRIN; FIBRONECTIN; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL INVASION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; OVARY CARCINOMA; PLASMID; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN DEPLETION; PROTEIN EXPRESSION; RNA INTERFERENCE; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANTIGENS, CD29; CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; FIBRONECTINS; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASMS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFECTION;

EID: 84856015401     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.10.032     Document Type: Article

References (82)

1. Li H., Fan X., Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. J. Cell. Biochem. 2007, 101:805-815.
2. Tlsty T.D., Coussens L.M. Tumor stroma and regulation of cancer development. Annu. Rev. Pathol. 2006, 1:119-150.
3. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
4. Bissell M.J., Radisky D. Putting tumours in context. Nat. Rev. Cancer 2001, 1:46-54.
5. Ingber D.E., Madri J.A., Jamieson J.D. Role of basal lamina in neoplastic disorganization of tissue architecture. Proc. Natl. Acad. Sci. USA 1981, 78:3901-3905.
6. Clark W.H. The nature of cancer: morphogenesis and progressive (self)-disorganization in neoplastic development and progression. Acta Oncol. 1995, 34:3-21.
7. Lukashev M.E., Werb Z. ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol. 1998, 8:437-441.
8. Rintoul R.C., Sethi T. The role of extracellular matrix in small-cell lung cancer. Lancet Oncol. 2001, 2:437-442.
9. Givant-Horwitz V., Davidson B., Reich R. Laminin-induced signaling in tumor cells. Cancer Lett. 2005, 223:1-10.
10. Orend G., Chiquet-Ehrismann R. Tenascin-C induced signaling in cancer. Cancer Lett. 2006, 244:143-163.
11. Jones F.S., Jones P.L. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev. Dyn. 2000, 218:235-259.
12. Ioachim E., Charchanti A., Briasoulis E., Karavasilis V., Tsanou H., Arvanitis D.L., Agnantis N.J., Pavlidis N. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. Eur. J. Cancer 2002, 38:2362-2370.
13. Rickert C.H., Paulus W. Prognosis-related histomorphological and immunohistochemical markers in central nervous system tumors of childhood and adolescence. Acta Neuropathol. 2005, 109:69-92.
14. Demeter A., Sziller I., Csapo Z., Olah J., Keszler G., Jeney A., Papp Z., Staub M. Molecular prognostic markers in recurrent and in non-recurrent epithelial ovarian cancer. Anticancer Res. 2005, 25:2885-2889.
15. McCormack V.A., dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1159-1169.
16. Andrews P.W. From teratocarcinomas to embryonic stem cells. Philos. Trans. R. Soc. London B Biol. Sci. 2002, 357:405-417.
17. Yamada K.M., Olden K. Fibronectins-adhesive glycoproteins of cell surface and blood. Nature 1978, 275:179-184.
18. Hynes R.O., Destree A.T., Perkins M.E., Wagner D.D. Cell surface fibronectin and oncogenic transformation. J. Supramol. Struct. 1979, 11:95-104.
19. Rutka J.T. The K.G. McKenzie award lecture - 1986. Effects of extracellular matrix proteins on the growth and differentiation of an anaplastic glioma cell line. Can. J. Neurol. Sci. 1986, 13:301-306.
20. Ruoslahti E. Integrin signaling and matrix assembly. Tumour Biol. 1996, 17:117-124.
21. Psaila B., Lyden D. The metastatic niche: adapting the foreign soil. Nat. Rev. Cancer 2009, 9:285-293.
22. Slack N.H., Bross I.D. The influence of site of metastasis on tumour growth and response to chemotherapy. Br. J. Cancer 1975, 32:78-86.
23. Tsuruo T., Fidler I.J. Differences in drug sensitivity among tumor cells from parental tumors, selected variants, and spontaneous metastases. Cancer Res. 1981, 41:3058-3064.
24. Fidler I.J., Wilmanns C., Staroselsky A., Radinsky R., Dong Z., Fan D. Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev. 1994, 13:209-222.
25. C L.A. Modulation of response to tumor therapies by the extracellular matrix. Future Oncol. 2006, 2:417-429.
26. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
27. Harburger D.S., Calderwood D.A. Integrin signalling at a glance. J. Cell Sci. 2009, 122:159-163.
28. Vicente-Manzanares M., Choi C.K., Horwitz A.R. Integrins in cell migration - the actin connection. J. Cell Sci. 2009, 122:199-206.
29. Muller E.J., Williamson L., Kolly C., Suter M.M. Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation?. J. Invest. Dermatol. 2008, 128:501-516.
30. Lock J.G., Wehrle-Haller B., Stromblad S. Cell-matrix adhesion complexes: master control machinery of cell migration. Semin. Cancer Biol. 2008, 18:65-76.
31. Banno A., Ginsberg M.H. Integrin activation. Biochem. Soc. Trans. 2008, 36:229-234.
32. Luo B.H., Carman C.V., Springer T.A. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 2007, 25:619-647.
33. Reddig P.J., Juliano R.L. Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev. 2005, 24:425-439.
34. Kim M., Carman C.V., Springer T.A. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 2003, 301:1720-1725.
35. Fagerholm S.C., Hilden T.J., Gahmberg C.G. P marks the spot: site-specific integrin phosphorylation regulates molecular interactions. Trends Biochem. Sci. 2004, 29:504-512.
36. ffrench-Constant C., Colognato H. Integrins: versatile integrators of extracellular signals. Trends Cell Biol. 2004, 14:678-686.
37. Wang L.H. Molecular signaling regulating anchorage-independent growth of cancer cells. Mt. Sinai J. Med. 2004, 71:361-367.
38. Schwartz M.A. Integrins, oncogenes, and anchorage independence. J. Cell Biol. 1997, 139:575-578.
39. Mizejewski G.J. Role of integrins in cancer: survey of expression patterns. Proc. Soc. Exp. Biol. Med. 1999, 222:124-138.
40. Danen E.H. Integrins: regulators of tissue function and cancer progression. Curr. Pharm. Des. 2005, 11:881-891.
41. Diaz L.K., et al. Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer. Mod. Pathol. 2005, 18:1165-1175.
42. Lipscomb E.A., Simpson K.J., Lyle S.R., Ring J.E., Dugan A.S., Mercurio A.M. The alpha6beta4 integrin maintains the survival of human breast carcinoma cells in vivo. Cancer Res. 2005, 65:10970-10976.
43. Cruz-Monserrate Z., Qiu S., Evers B.M., O'Connor K.L. Upregulation and redistribution of integrin alpha6beta4 expression occurs at an early stage in pancreatic adenocarcinoma progression. Mod. Pathol. 2007, 20:656-667.
44. Rabinovitz I., Nagle R.B., Cress A.E. Integrin alpha 6 expression in human prostate carcinoma cells is associated with a migratory and invasive phenotype in vitro and in vivo. Clin. Exp. Metastasis 1995, 13:481-491.
45. Cress A.E., Rabinovitz I., Zhu W., Nagle R.B. The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression. Cancer Metastasis Rev. 1995, 14:219-228.
46. Damiano J.S. Integrins as novel drug targets for overcoming innate drug resistance. Curr. Cancer Drug Targets 2002, 2:37-43.
47. Estrugo D., Fischer A., Hess F., Scherthan H., Belka C., Cordes N. Ligand bound beta1 integrins inhibit procaspase-8 for mediating cell adhesion-mediated drug and radiation resistance in human leukemia cells. PLoS ONE 2007, 2:e269.
48. Cordes N., Seidler J., Durzok R., Geinitz H., Brakebusch C. Beta1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury. Oncogene 2006, 25:1378-1390.
49. Debnath J., Muthuswamy S.K., Brugge J.S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003, 30:256-268.
50. Freedman V.H., Shin S.I. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 1974, 3:355-359.
51. Cukierman E., Pankov R., Stevens D.R., Yamada K.M. Taking cell-matrix adhesions to the third dimension. Science 2001, 294:1708-1712.
52. Humphries J.D., Byron A., Humphries M.J. Integrin ligands at a glance. J. Cell Sci. 2006, 119:3901-3903.
53. Wayner E.A., Gil S.G., Murphy G.F., Wilke M.S., Carter W.G. Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes. J. Cell Biol. 1993, 121:1141-1152.
54. Takada Y., Puzon W. Identification of a regulatory region of integrin beta 1 subunit using activating and inhibiting antibodies. J. Biol. Chem. 1993, 268:17597-17601.
55. Wang J.H., Manning B.J., Wu Q.D., Blankson S., Bouchier-Hayes D., Redmond H.P. Endotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism. J. Immunol. 2003, 170:795-804.
56. Mosher D.F., Sottile J., Wu C., McDonald J.A. Assembly of extracellular matrix. Curr. Opin. Cell Biol. 1992, 4:810-818.
57. den Braber E.T., de Ruijter J.E., Ginsel L.A., von Recum A.F., Jansen J.A. Orientation of ECM protein deposition, fibroblast cytoskeleton, and attachment complex components on silicone microgrooved surfaces. J. Biomed. Mater. Res. 1998, 40:291-300.
58. Weaver V.M., Petersen O.W., Wang F., Larabell C.A., Briand P., Damsky C., Bissell M.J. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 1997, 137:231-245.
59. Zhang X., Fournier M.V., Ware J.L., Bissell M.J., Yacoub A., Zehner Z.E. Inhibition of vimentin or beta1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo. Mol. Cancer Ther. 2009, 8:499-508.
60. Radeva G., Petrocelli T., Behrend E., Leung-Hagesteijn C., Filmus J., Slingerland J., Dedhar S. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J. Biol. Chem. 1997, 272:13937-13944.
61. Kumar A.S., Naruszewicz I., Wang P., Leung-Hagesteijn C., Hannigan G.E. ILKAP regulates ILK signaling and inhibits anchorage-independent growth. Oncogene 2004, 23:3454-3461.
62. Frisch S.M., Vuori K., Ruoslahti E., Chan-Hui P.Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 1996, 134:793-799.
63. Glimelius B., Norling B., Nederman T., Carlsson J. Extracellular matrices in multicellular spheroids of human glioma origin: increased incorporation of proteoglycans and fibronectin as compared to monolayer cultures. APMIS 1988, 96:433-444.
64. Nederman T., Norling B., Glimelius B., Carlsson J., Brunk U. Demonstration of an extracellular matrix in multicellular tumor spheroids. Cancer Res. 1984, 44:3090-3097.
65. Qiao H., Saulnier R., Patryzkat A., Rahimi N., Raptis L., Rossiter J., Tremblay E., Elliott B. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity. Cell Growth Differ. 2000, 11:123-133.
66. Saulnier R., Bhardwaj B., Klassen J., Leopold D., Rahimi N., Tremblay E., Mosher D., Elliott B. Fibronectin fibrils and growth factors stimulate anchorage-independent growth of a murine mammary carcinoma. Exp. Cell Res. 1996, 222:360-369.
67. Varner J.A., Emerson D.A., Juliano R.L. Integrin alpha 5 beta 1 expression negatively regulates cell growth: reversal by attachment to fibronectin. Mol. Biol. Cell 1995, 6:725-740.
68. Zhang Z., Vuori K., Reed J.C., Ruoslahti E. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. USA 1995, 92:6161-6165.
69. Lee B.H., Ruoslahti E. Alpha5beta1 integrin stimulates Bcl-2 expression and cell survival through Akt, focal adhesion kinase, and Ca2 +/calmodulin-dependent protein kinase IV. J. Cell Biochem. 2005, 95:1214-1223.
70. Farias E., Lu M., Li X., Schnapp L.M. Integrin alpha8beta1-fibronectin interactions promote cell survival via PI3 kinase pathway. Biochem. Biophys. Res. Commun. 2005, 329:305-311.
71. Jang Y.C., Arumugam S., Ferguson M., Gibran N.S., Isik F.F. Changes in matrix composition during the growth and regression of human hemangiomas. J. Surg. Res. 1998, 80:9-15.
72. Lochter A., Bissell M.J. Involvement of extracellular matrix constituents in breast cancer. Semin. Cancer Biol. 1995, 6:165-173.
73. Sengupta S., Nandi S., Hindi E.S., Wainwright D.A., Han Y., Lesniak M.S. Short hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model. Neoplasia 2010, 12:837-847.
74. Jia D., et al. Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion. BMC Cancer 2011, 10:364.
75. Gaggioli C., et al. Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway. J. Invest. Dermatol. 2007, 127:400-410.
76. Goel H.L., Underwood J.M., Nickerson J.A., Hsieh C.C., Languino L.R. Beta1 integrins mediate cell proliferation in three-dimensional cultures by regulating expression of the sonic hedgehog effector protein, GLI1. J. Cell Physiol. 2010, 224:210-217.
77. Yang C., Zeisberg M., Lively J.C., Nyberg P., Afdhal N., Kalluri R. Integrin alpha1beta1 and alpha2beta1 are the key regulators of hepatocarcinoma cell invasion across the fibrotic matrix microenvironment. Cancer Res. 2003, 63:8312-8317.
78. Han S., Ritzenthaler J.D., Sitaraman S.V., Roman J. Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J. Biol. Chem. 2006, 281:29614-29624.
79. Maity G., Choudhury P.R., Sen T., Ganguly K.K., Sil H., Chatterjee A. Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity. Tumour Biol. 2010, 32:129-138.
80. Sen T., Dutta A., Maity G., Chatterjee A. Fibronectin induces matrix metalloproteinase-9 (MMP-9) in human laryngeal carcinoma cells by involving multiple signaling pathways. Biochimie 2010, 92:1422-1434.
81. Esparza J., Vilardell C., Calvo J., Juan M., Vives J., Urbano-Marquez A., Yague J., Cid M.C. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood 1999, 94:2754-2766.
82. Dechow T.N., Pedranzini L., Leitch A., Leslie K., Gerald W.L., Linkov I., Bromberg J.F. Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C. Proc. Natl. Acad. Sci. USA 2004, 101:10602-10607.